Most lately, it has been discovered that conolidine and the above mentioned derivatives act on the atypical chemokine receptor three (ACKR3. Expressed in identical spots as classical opioid receptors, it binds to a big range of endogenous opioids. Compared with most opioid receptors, this receptor acts to be a scavenger and would not activate a 2nd